Liver transplantation is not indicated for cholangiocarcinoma

Abstract
Cholangiocarcinoma (CCA) accounts for <2% of all human malignancies and only 10% of hepatobiliary malignancies. The 1‐year survival rate for patients with CCA is around 25%. Survival can be improved with grossly complete surgical resection. Unfortunately, CCA often presents (50–90%) with advanced stage (III and IV) and locoregional spread, making this complete resection difficult or impossible. The surgical resection must be extensive, often including partial hepatectomy [1x1Lee, S.G., Lee, Y.J., Park, K.M., Hwang, S., and Min, P.C. One hundred and eleven liver resections for hilar bile duct cancer. J Hepatobiliary Pancreat Surg. 2000; 7: 135–141Crossref | PubMed | Scopus (124) | Google ScholarSee all References1].